Study Details

Back
Study ID 178-CL-045
Study Title YM178 Phase II study - A Randomized, Double-blind, Parallel-group, Placebo-controlled Study in Patients With Symptomatic Overactive Bladder -(Original language of CSR synopsis is Japanese.)
Clinicaltrials.gov Identifier NCT00527033
Compound Name YM178 / mirabegron
Medical Indication or Disease Overactive bladder
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 11-Sep-2007
Study Completion Date 03-Apr-2008
Clinical Study Result
Select the language
Japanese
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS